TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8805964

Group type: EXPERIMENTAL
Intervention: Relaxation with Mucosal Immune Imagery (RI)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Relaxation Alone (R)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Vigilance Task control (VT)
Number of subjects: 121
Study: 1457907

Group type: EXPERIMENTAL
Intervention: Quinine 325 mg at bedtime
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Vitamin E 400 IU at bedtime
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo washout (baseline)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Severity of pain index
Number of subjects: 40
Study: 6694348

Group type: EXPERIMENTAL
Intervention: 8 hours training per week
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control (3 1/2 hours training per week)
Number of subjects: 33
Study: 31165869

Group type: EXPERIMENTAL
Intervention: Intensive behavior change interventions (IPC, AG, CM, MM)
Number of subjects: 2646
Study: 28902105

Group type: EXPERIMENTAL
Intervention: Pulsed Radiofrequency (PRF) stimulation
Number of subjects: 23

Group type: COMPARATOR
Intervention: Intra-articular Corticosteroid Injection (ICI)
Number of subjects: 23
Study: 27388828

Group type: EXPERIMENTAL
Intervention: Paclitaxel-based drug-eluting balloon (DEB) angioplasty (n = 35)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Standard percutaneous transluminal angioplasty (PTA) (n = 39)
Number of subjects: 74
Study: 24935999

Group type: EXPERIMENTAL
Intervention: Caffeine 1 mg/kg
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Caffeine 2 mg/kg
Number of subjects: 202

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Caffeine (both doses)
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Caffeine in post‐pubertal girls
Number of subjects: 202
Study: 22511570

Group type: EXPERIMENTAL
Intervention: Work place ergonomic intervention
Number of subjects: 89

Group type: COMPARATOR
Intervention: Control (provision of written educational materials)
Number of subjects: 89
Study: 20613496

Group type: EXPERIMENTAL
Intervention: Combination of telmisartan (80 mg) and amlodipine (10 mg)
Number of subjects: 562

Group type: COMPARATOR
Intervention: Amlodipine (10 mg)
Number of subjects: 562

Group type: COMPARATOR
Intervention: Telmisartan (80 mg)
Number of subjects: 562

Group type: EXPERIMENTAL
Intervention: Combination therapy
Number of subjects: 562
Study: 18042475

Group type: EXPERIMENTAL
Intervention: Rosuvastatin 5 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Rosuvastatin 10 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Rosuvastatin 20 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Rosuvastatin 10 mg (fed state)
Number of subjects: 12
Study: 15122133

Group type: EXPERIMENTAL
Intervention: 0.2% ropivacaine PCA infusion at 5 mL per hour with a bolus dose of 2 mL at a 15-minute lockout period (group I)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Saline infusion under the same conditions (group II)
Number of subjects: 24
Study: 12377962

Group type: EXPERIMENTAL
Intervention: Gemcitabine with cisplatin
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Paclitaxel with cisplatin
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Vinorelbine with cisplatin
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: All arms (gemcitabine, paclitaxel, vinorelbine with cisplatin)
Number of subjects: 175
Study: 9619811

Group type: EXPERIMENTAL
Intervention: Willingness to participate in a randomized vaccine efficacy trial
Number of subjects: 4892

Group type: EXPERIMENTAL
Intervention: Factors influencing decision-making
Number of subjects: 4892

Group type: EXPERIMENTAL
Intervention: Motivators for participation
Number of subjects: 4892

Group type: EXPERIMENTAL
Intervention: Concerns regarding participation
Number of subjects: 4892

Group type: EXPERIMENTAL
Intervention: Baseline knowledge of vaccine trial concepts
Number of subjects: 4892
Study: 8087909

Group type: EXPERIMENTAL
Intervention: Sugarless gum chewing (Group 2)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Control group (Group 1)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Sugarless gum chewing (Group 3)
Number of subjects: 77
Study: 2781237

Group type: EXPERIMENTAL
Intervention: Erosive prepyloric changes (EPC) grade 2 or 3
Number of subjects: 60
Study: 326495

Group type: EXPERIMENTAL
Intervention: Indapamide (2.5 mg to 5 mg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 31556099

Group type: EXPERIMENTAL
Intervention: Atopic dermatitis (AD) severity
Number of subjects: 3834

Group type: EXPERIMENTAL
Intervention: Pain medication use in AD patients
Number of subjects: 3834

Group type: EXPERIMENTAL
Intervention: Skin pain scores in AD patients
Number of subjects: 3834

Group type: COMPARATOR
Intervention: Comparison of pain medication use
Number of subjects: 3834
Study: 31092664

Group type: EXPERIMENTAL
Intervention: MyBackPain.org.au website access
Number of subjects: 440

Group type: COMPARATOR
Intervention: Publicly available online information (control group)
Number of subjects: 440
Study: 28068596

Group type: EXPERIMENTAL
Intervention: Aspirin plus omega 3
Number of subjects: 80

Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 80
Study: 27260482

Group type: EXPERIMENTAL
Intervention: Ultrashort anatomic cementless stem
Number of subjects: 200

Group type: COMPARATOR
Intervention: Conventional anatomic cementless stem
Number of subjects: 200
Study: 24474088

Group type: EXPERIMENTAL
Intervention: Cemented femoral stem with polished finish and collar
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Cemented femoral stem with matt finish and collar
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Cemented femoral stem with polished finish and collarless
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Cemented femoral stem with matt finish and collarless
Number of subjects: 163

Group type: COMPARATOR
Intervention: Cemented femoral stem with matt collarless
Number of subjects: 163

Group type: COMPARATOR
Intervention: Cemented femoral stem with polished collarless
Number of subjects: 163
Study: 21204889

Group type: EXPERIMENTAL
Intervention: Chemotherapy with VCE supplementation (vitamin C 500 mg tablet and vitamin E 400 mg gelatin capsule)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Chemotherapy alone (5‐fluorouracil 500 mg/m(2) i.v. day 1, doxorubicin 50 mg/m(2) i.v. day 1, cyclophosphamide 500 mg/m(2) i.v. day 1, every 3 weeks for six cycles)
Number of subjects: 40
Study: 19852273

Group type: COMPARATOR
Intervention: Terazosin
Number of subjects: 168

Group type: COMPARATOR
Intervention: Chlormezanone
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Terazosin + Chlormezanone
Number of subjects: 168
Study: 17445266

Group type: EXPERIMENTAL
Intervention: 200 mg 5-ALA via inhalation 1, 2, 3, 4 or 6 hours before bronchoscopy
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: 200 mg 5-ALA via inhalation
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: 200 mg 5-ALA via inhalation 160 min prior to bronchoscopy
Number of subjects: 19
Study: 15610951

Group type: EXPERIMENTAL
Intervention: High dose transdermal nicotine patch (14 or 21 mg)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Low dose transdermal nicotine patch (7 mg)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Control group (no nicotine patch)
Number of subjects: 85
Study: 12200355

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (UDCA) 12 mg/kg/d orally from the day preceding conditioning until day 90 after transplantation
Number of subjects: 242

Group type: COMPARATOR
Intervention: Control group (no UDCA)
Number of subjects: 242
Study: 10443309

Group type: EXPERIMENTAL
Intervention: Arterial rigidity measurements
Number of subjects: 0

Group type: COMPARATOR
Intervention: Framingham equation
Number of subjects: 0
Study: 7579052

Group type: EXPERIMENTAL
Intervention: Low-protein diet group
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Low blood pressure group
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Low MAP group
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Lower protein intake
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Prescription of the keto acid‐amino acid supplement
Number of subjects: 200
Study: 2357862

Group type: EXPERIMENTAL
Intervention: 400 mg caffeine plus 75 mg phenylpropanolamine
Number of subjects: 16

Group type: COMPARATOR
Intervention: 400 mg caffeine alone
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: phenylpropanolamine-caffeine combination
Number of subjects: 16
Study: 6153904

Group type: EXPERIMENTAL
Intervention: argon laser photocoagulation
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: xenon photocoagulation
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control (untreated eye)
Number of subjects: 67
Study: 31004574

Group type: EXPERIMENTAL
Intervention: Fibrinogen concentrate
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: TEG
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: ROTEM
Number of subjects: 45

Group type: COMPARATOR
Intervention: CCTs
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: TEG and ROTEM
Number of subjects: 45
Study: 28477398

Group type: EXPERIMENTAL
Intervention: One-to-one simulated patient (SP) training with individual feedback
Number of subjects: 236

Group type: COMPARATOR
Intervention: Small-group SP training with collective feedback
Number of subjects: 236
Study: 25589326

Group type: EXPERIMENTAL
Intervention: Albendazole plus oxantel pamoate (400 mg + 20 mg/kg)
Number of subjects: 440

Group type: EXPERIMENTAL
Intervention: Albendazole plus ivermectin (400 mg + 200 μg/kg)
Number of subjects: 440

Group type: COMPARATOR
Intervention: Mebendazole alone (500 mg)
Number of subjects: 440

Group type: EXPERIMENTAL
Intervention: Albendazole plus mebendazole (400 mg + 500 mg)
Number of subjects: 440
Study: 24495468

Group type: EXPERIMENTAL
Intervention: Melatonin 3 mg orally
Number of subjects: 78

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78
Study: 22967344

Group type: EXPERIMENTAL
Intervention: Acarbose 50 mg added to insulin treatment
Number of subjects: 120

Group type: COMPARATOR
Intervention: Preprandial ultra-short effect insulin and long-acting insulin before bedtime (Control group)
Number of subjects: 120
Study: 19926783

Group type: EXPERIMENTAL
Intervention: 125 microg T(4)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: 250 microg T(4)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: 25 microg T(3)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: 50 microg T(3)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 17986032

Group type: EXPERIMENTAL
Intervention: Oral midazolam 0.5 mg.kg (‐1)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Oral clonidine 4 microg.kg (‐1)
Number of subjects: 64
Study: 15945402

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (400 IU daily)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study: 12194554

Group type: EXPERIMENTAL
Intervention: Laparoscopic adjustable gastric banding
Number of subjects: 52

Group type: COMPARATOR
Intervention: Adjustable esophagogastric banding
Number of subjects: 52
Study: 9456288

Group type: EXPERIMENTAL
Intervention: celiprolol (200-400 mg daily)
Number of subjects: 25
Study: 7497033

Group type: EXPERIMENTAL
Intervention: Modified Allen's test
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Pulse oximetry
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Plethysmography
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Laser Doppler perfusion monitoring
Number of subjects: 74
Study: 2119168

Group type: EXPERIMENTAL
Intervention: sorbinil (250 mg daily for 3 years)
Number of subjects: 497

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 497

Group type: EXPERIMENTAL
Intervention: sorbinil
Number of subjects: 497
Study: 7435677

Group type: EXPERIMENTAL
Intervention: Amitriptyline alone, up to a maximum dose of 300 mg/day
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Tranylcypromine alone, up to a maximum dose of 40 mg/day
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Combination of amitriptyline (up to 150 mg/day) and tranylcypromine (up to 20 mg/day)
Number of subjects: 30
Study: 30606469

Group type: EXPERIMENTAL
Intervention: ERAS program
Number of subjects: 180

Group type: COMPARATOR
Intervention: Standard care protocol
Number of subjects: 180
Study: 28077732

Group type: EXPERIMENTAL
Intervention: High-Protein breakfast (19-20 g protein)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: High-Fiber breakfast (10-11 g fiber)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Combined High-Protein and High-Fiber breakfast (19-21 g protein, 10-12 g fiber)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Usual breakfast (control)
Number of subjects: 41
Study: 26298524

Group type: EXPERIMENTAL
Intervention: Intensive dietary educational program with instructions to follow a conventional energy restricted diet
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group following the same healthy diet without calorie restriction
Number of subjects: 60
Study: 24036466

Group type: EXPERIMENTAL
Intervention: Anodal transcranial direct current stimulation (atDCS) applied for 20 minutes to the primary motor cortex (M1)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham transcranial direct current stimulation (stDCS)
Number of subjects: 0
Study: 21233605

Group type: EXPERIMENTAL
Intervention: Laparoscopic Nissen fundoplication
Number of subjects: 175

Group type: COMPARATOR
Intervention: Laparoscopic Thal fundoplication
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 175
Study: 20054083

Group type: EXPERIMENTAL
Intervention: Virtual Ventilator computer simulation (SIM-1st)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Live-animal mechanical ventilation laboratory (LIVE-1st)
Number of subjects: 109
Study: 17717919

Group type: EXPERIMENTAL
Intervention: Qifang Weitong Powder combined with omeprazole (QWP‐Op)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Omeprazole alone
Number of subjects: 60
Study: 16877627

Group type: EXPERIMENTAL
Intervention: Experimental drug outside of a study
Number of subjects: 420

Group type: EXPERIMENTAL
Intervention: New drug as part of a study
Number of subjects: 420

Group type: EXPERIMENTAL
Intervention: Randomised controlled trial (RCT) for a new drug
Number of subjects: 420

Group type: EXPERIMENTAL
Intervention: Study of thoracotomy
Number of subjects: 420

Group type: EXPERIMENTAL
Intervention: Study requiring placement of a femoral catheter
Number of subjects: 420
Study: 12640509

Group type: EXPERIMENTAL
Intervention: Fluvastatin 40 mg/day
Number of subjects: 41

Group type: COMPARATOR
Intervention: Pravastatin 20 mg/day
Number of subjects: 41
Study: 10852357

Group type: EXPERIMENTAL
Intervention: 12-month treatment programs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Longer residential treatment program
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Number of prior arrests
Number of subjects: 0
Study: 8843935

Group type: EXPERIMENTAL
Intervention: Voice bulletin board
Number of subjects: 53
Study: 1640226

Group type: EXPERIMENTAL
Intervention: Enhanced therapy regime (increased treatment and behavioral methods)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Orthodox physiotherapy
Number of subjects: 132
Study: 6384911

Group type: EXPERIMENTAL
Intervention: A.C.T. (Asthma Care Training) for Kids - 5 sessions of 1 hour each
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control group - 4 1/2 hours of lecture presentations on asthma and its management
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Experimental group
Number of subjects: 76
Study: 31897315

Group type: EXPERIMENTAL
Intervention: Lignocaine spray (1 puff, 1.5 mg/kg)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Nitroglycerin spray (1 puff, 400 μg)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 90
Study: 28824850

Group type: EXPERIMENTAL
Intervention: iPad-based cognitive training (CT)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Desktop-based cognitive training (CT)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 74
Study: 26656984

Group type: EXPERIMENTAL
Intervention: Practice level intervention over 6 months including small group training, feedback on audited performance, practice facilitation visits, and provision of patient education and referral information.
Number of subjects: 122

Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Practice level intervention.
Number of subjects: 122
Study: 24217426

Group type: EXPERIMENTAL
Intervention: structured exercise
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: lifestyle exercise
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: exercise
Number of subjects: 221
Study: 21457426

Group type: EXPERIMENTAL
Intervention: Pioglitazone (45 mg)
Number of subjects: 5238

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5238
Study: 18708008

Group type: EXPERIMENTAL
Intervention: Red crowding bars
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Green crowding bars
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Yellow crowding bars
Number of subjects: 101

Group type: COMPARATOR
Intervention: Black crowding bars
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Red crowding bars in second phase
Number of subjects: 101
Study: 17083289

Group type: EXPERIMENTAL
Intervention: Single direction change in color and motion stimulus
Number of subjects: 0
Study: 15389355

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 11423812

Group type: EXPERIMENTAL
Intervention: Sequential presentation format
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Grouped presentation format
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control specimen (before SF administration)
Number of subjects: 10
Study: 9245846

Group type: EXPERIMENTAL
Intervention: Information booklet and verbal counselling
Number of subjects: 200

Group type: COMPARATOR
Intervention: Verbal counselling only
Number of subjects: 200
Study: 8490197

Group type: EXPERIMENTAL
Intervention: CMF (cyclophosphamide, methotrexate and 5‐fluorouracil, every 3 weeks)
Number of subjects: 38

Group type: COMPARATOR
Intervention: CXF (cyclophosphamide, mitoxantrone and 5‐fluorouracil, every 3 weeks)
Number of subjects: 38
Study: 3106448

Group type: EXPERIMENTAL
Intervention: Parenteral gold therapy
Number of subjects: 8
Study: 30761786

Group type: EXPERIMENTAL
Intervention: Canephron N (2 tablets 3 times daily for 30 days)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Ciprofloxacin (0.5 g twice daily for 3 days)
Number of subjects: 160
Study: 27274223

Group type: EXPERIMENTAL
Intervention: Pressure-regulated volume control (PRVC) ventilation
Number of subjects: 39

Group type: COMPARATOR
Intervention: Synchronized intermittent mandatory ventilation - volume control
Number of subjects: 39
Study: 25382328

Group type: EXPERIMENTAL
Intervention: High dose atorvastatin 80 mg/d (HD group)
Number of subjects: 165

Group type: COMPARATOR
Intervention: Normal dose atorvastatin 20 mg/d (ND group)
Number of subjects: 165

Group type: COMPARATOR
Intervention: Loading dose atorvastatin 80 mg followed by 20 mg/d (LD group)
Number of subjects: 165
Study: 23519529

Group type: COMPARATOR
Intervention: Group 1: 10 mg of lutein, 1 mg of zeaxanthin, 100 mg of docosahexaenoic acid, and 30 mg of eicosapentaenoic acid daily
Number of subjects: 172

Group type: COMPARATOR
Intervention: Group 2: Double the dose of Group 1
Number of subjects: 172

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 172
Study: 20943956

Group type: EXPERIMENTAL
Intervention: 10 mg Zn/d as Zn sulfate
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: 20 mg Zn/d as Zn sulfate
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study: 19097473

Group type: EXPERIMENTAL
Intervention: Clinical rest condition before and after the execution of exercises (a series of mandibular movements)
Number of subjects: 8
Study: 16617390

Group type: EXPERIMENTAL
Intervention: (99m)Tc‐DMSA renal scintigraphy in children with UTI and VUR
Number of subjects: 343

Group type: EXPERIMENTAL
Intervention: (99m)Tc‐DMSA renal scintigraphy in children with UTI without VUR
Number of subjects: 343

Group type: EXPERIMENTAL
Intervention: (99m)Tc‐DMSA renal scintigraphy in children with VUR grades I, II, III, IV and V
Number of subjects: 343
Study: 12895359

Group type: EXPERIMENTAL
Intervention: Rigid gas‐permeable lens (RGP)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Soft contact lens (SCL)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Spectacles with resin lens material (SP)
Number of subjects: 23
Study: 10935308

Group type: EXPERIMENTAL
Intervention: Sonographic measurements of fetal growth parameters (biparietal diameter, head circumference, abdominal diameter, abdominal circumference, femur length)
Number of subjects: 10043
Study: 8994098

Group type: EXPERIMENTAL
Intervention: Bacterial meningitis
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Viral meningitis
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Neutrophil granulocytes
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Lymphocytes and monocytes/macrophages
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: TGF beta 1
Number of subjects: 23
Study: 1618564

Group type: EXPERIMENTAL
Intervention: Skin traction
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Skeletal traction
Number of subjects: 80

Group type: COMPARATOR
Intervention: No traction (control)
Number of subjects: 80
Study: 6322489

Group type: EXPERIMENTAL
Intervention: Absorbable polyglycolic acid sutures (Dexon)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Non-absorbable sutures (Dacron)
Number of subjects: 58
Study: 30926065

Group type: EXPERIMENTAL
Intervention: Cetuximab
Number of subjects: 85

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 85
Study: 30383205

Group type: EXPERIMENTAL
Intervention: Intravitreal lampalizumab treatment
Number of subjects: 77
Study: 29927182

Group type: EXPERIMENTAL
Intervention: MDI with DIY spacer
Number of subjects: 40

Group type: COMPARATOR
Intervention: Nebulizer
Number of subjects: 40
Study: 25496727

Group type: EXPERIMENTAL
Intervention: Spirulina supplementation combined with local diet
Number of subjects: 169

Group type: COMPARATOR
Intervention: Local diet only
Number of subjects: 169
Study: 23328702

Group type: EXPERIMENTAL
Intervention: 400 µg/day folic acid
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 20040705

Group type: EXPERIMENTAL
Intervention: Integrated care intervention
Number of subjects: 58

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 58